Unicycive Therapeutics, Inc. (UNCY)
Data as of , from SEC Form 4 filings.
See up to 3 months of UNCY. The 7-day demo opens the 1M and 3M ranges and puts UNCY on your watchlist.
Start 7-day demoLatest UNCY insider trades
About Unicycive Therapeutics, Inc. (UNCY)
The SEC lists Unicycive Therapeutics, Inc. under CIK 0001766140, in pharmaceutical preparations. It is grouped with Health Care companies on this site.
UNCY Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 2 | 95,882 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
UNCY insider transactions (Form 4)
2923 Form 4 filings on record, the earliest from Oct 10, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sara Kenkare-Mitra - Director | Grant or award | Restricted Stock Units | 47,941 | $0.00 | - | |
| Sandeep Laumas - Director | Grant or award | Restricted Stock Units | 47,941 | $0.00 | - | |
| Shalabh K. Gupta - Officer | Grant or award | Restricted Stock Units | 762,200 | $0.00 | - | |
| Sara Kenkare-Mitra - Director | Grant or award | Restricted Stock Units | 84,200 | $0.00 | - | |
| Sara Kenkare-Mitra - Director | Grant or award | Restricted Stock Units | 42,100 | $0.00 | - | |
| Sandeep Laumas - Director | Grant or award | Restricted Stock Units | 84,200 | $0.00 | - | |
| Sandeep Laumas - Director | Grant or award | Restricted Stock Units | 42,100 | $0.00 | - | |
| Pramod Gupta - Officer | Grant or award | Restricted Stock Unit | 169,500 | $0.00 | - | |
 John Townsend - Officer | Grant or award | Restricted Stock Unit | 169,500 | $0.00 | - | |
| Douglas Jermasek - Officer | Grant or award | Restricted Stock Units | 169,500 | $0.00 | - | |
| Shalabh K. Gupta - Officer | Grant or award | Restricted Stock Units | 762,200 | $0.00 | - | |
| Sara Kenkare-Mitra - Director | Grant or award | Restricted Stock Units | 84,200 | $0.00 | - | |
| Sara Kenkare-Mitra - Director | Grant or award | Restricted Stock Units | 42,100 | $0.00 | - | |
| Douglas Jermasek - Officer | Grant or award | Restricted Stock Units | 169,500 | $0.00 | - | |
| Pramod Gupta - Officer | Grant or award | Restricted Stock Unit | 169,500 | $0.00 | - | |
| John Townsend - Officer | Grant or award | Restricted Stock Unit | 169,500 | $0.00 | - | |
| Sandeep Laumas - Director | Grant or award | Restricted Stock Units | 84,200 | $0.00 | - | |
| Sandeep Laumas - Director | Grant or award | Restricted Stock Units | 42,100 | $0.00 | - | |
| Gaurav Aggarwal - Director | Other | Common Stock | 652,900 | - | - | |
| Gaurav Aggarwal - Director | Derivative | Series A-2 Prime Preferred Stock | 3,199 | $1,000.00 | $3.20M | |
| Sara Kenkare-Mitra - Director | Grant or award | Stock Options | 21,200 | $0.00 | - | |
| Shalabh K. Gupta - Officer | Grant or award | Stock Options | 325,000 | $0.00 | - | |
| Pramod Gupta - Officer | Grant or award | Stock Options | 90,000 | $0.00 | - | |
| Douglas Jermasek - Officer | Grant or award | Stock Options | 10,000 | $0.00 | - | |
| Sandeep Laumas - Director | Grant or award | Stock Options | 21,200 | $0.00 | - | |
| Gaurav Aggarwal - Director | Grant or award | Stock Options | 21,200 | $0.00 | - | |
| John Townsend - Officer | Grant or award | Stock Options | 10,000 | $0.00 | - | |
| Gaurav Aggarwal - Director | Other | Common Stock | 5,500,000 | - | - | |
| Gaurav Aggarwal - Director | Derivative | Series A-2 Prime Preferred Stock | 2,695 | $1,000.00 | $2.69M |
Recent UNCY Form 144 notices of proposed sale
1An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
UNCY insider trading FAQ
What is the latest insider trade for UNCY?
Unicycive Therapeutics, Inc. (UNCY) had 2 insider filings in the last 90 days, with the most recent on 2026-07-28. The full record for UNCY runs to 23 Form 4 filings, the earliest from 2024-10-10. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying UNCY stock?
No insider purchases of UNCY were filed in the last 90 days.
How many insiders are selling UNCY stock?
No insider sales of UNCY were filed in the last 90 days.
Where can I see UNCY SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects UNCY Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Sara Kenkare-Mitra view on EDGAR
- - Sandeep Laumas view on EDGAR
- - Shalabh K. Gupta view on EDGAR
- - Sara Kenkare-Mitra view on EDGAR
- - Sandeep Laumas view on EDGAR
- - Pramod Gupta view on EDGAR
- - John Townsend view on EDGAR
- - Douglas Jermasek view on EDGAR
- - Shalabh K. Gupta view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where UNCY's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow UNCY with a 7-day demo
- UNCY on your watchlist
- Every UNCY Form 4 filing on record
- Up to 3 months of UNCY price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
